Welcome to the CPDD 2006 Conference. This slide show was prepared to recognize and celebrate the acc - PowerPoint PPT Presentation

1 / 110
About This Presentation

Welcome to the CPDD 2006 Conference. This slide show was prepared to recognize and celebrate the acc


The House of Hope and Horizon House in Columbia, S.C., serve the homeless who ... I conduct research in the New York City metropolitan area and the foci of my ... – PowerPoint PPT presentation

Number of Views:693
Avg rating:3.0/5.0
Slides: 111
Provided by: UTM8
Learn more at: http://www.cpdd.vcu.edu


Transcript and Presenter's Notes

Title: Welcome to the CPDD 2006 Conference. This slide show was prepared to recognize and celebrate the acc

Welcome to the CPDD 2006 Conference. This slide
show was prepared to recognize and celebrate the
accomplishments of 128 award winners for 2006.
F. Ivy Carroll, Ph.D. Nathan B. Eddy Award
As Director of Organic and Medicinal Chemistry
and Distinguished Fellow at the Research Triangle
Institute, my research studies have provided
pharmacological tools and potential
pharmacotherapies for substance abuse. We have
developed compounds that target monoamine
transporters, opioid receptors and nicotinic
receptors and promise success as
pharmacotherapies in addiction.
R. Christopher Pierce, Ph.D. Joseph Cochin Young
Investigator Award
I received a Ph.D. in neuroscience and psychology
from Indiana University in 1993.  I am currently
Associate Professor of Pharmacology and
Psychiatry at Boston University School of
Medicine.  My research focuses on the cellular
and molecular mechanisms underlying cocaine
craving using animal models.
Lynda A. Dykstra, M.A., Ph.D. Marian W. Fischman
Lectureship Award
For over 30 years, I have led an active research
program, focusing on the behavioral pharmacology
of opioid analgesics, both in relation to their
pain-relieving properties as well as their
tendency to produce tolerance and dependence. A
more recent research interest of my laboratory is
the investigation of behavioral phenotypes
related to substance abuse using genetically
altered mice.
Joseph Frascella, Ph.D. J. Michael Morrison Award
I am the Director of the Division of Clinical
Neuroscience and Behavioral Research at NIDA,
which covers a broad drug abuse and addiction
program of translational research and research
training in clinical neuroscience, human
development, and behavioral treatment. I also
served as the Chief of the Clinical Neurobiology
Branch, and started my career at NIDA in the
Neuroscience Research Branch with Roger Brown.
James C. Anthony, Ph.D. CPDD Mentorship Award
I am conducting field studies to answer questions
about the hazards of drug use in the U.S., four
U.S. territories, and multiple countries (Latin
America, Caribbean, Micronesia). My current
research utilizes longitudinal designs with
randomized interventions to study underlying
susceptibility traits, conditions, and processes
that influence rapid transitions through stages
of drug involvement.
Richard M. Eisenberg, Ph.D. CPDD Distinguished
Service Award
I received my Ph.D. in 1970 from the U.C.L.A
Department of Pharmacology. In my career, I have
studied opiate dependence/tolerance and now
produces educational software. I am the Chair of
the CPDD Electronics Committee.
Harvey Weiss, M.B.A. CPDD Media Award
I am the Founder and Executive Director of the
National Inhalant Prevention Coalition
(NIPC), whose goal is to develop awareness and
prevention campaigns to educate youth and adults
about the debilitating effects of inhalants.
Since its inception, the NIPC has received
widespread media coverage, including feature
stories in New York Times, and CNN Newsstand,
 and established National Inhalants and Poisons
Awareness Week (NIPAW). 
Jonathan B. Kamien, Ph.D. CPDD Distinguished
Service Award
At age ten, I decided to be an experimental
psychologist. Seventeen years later, after
receiving a BA from Middlebury College in 1982, I
was awarded a Ph.D. from the University of
Chicago in 1987. I have been studying the
discriminative stimulus effects of drugs and
behavioral treatments for drug dependence ever
Sara Jane Ward, Ph.D.CPDD Early Career
Investigator Travel AwardMentors Linda A.
Dykstra, Ph.D., Ellen A. Walker, Ph.D.
The cannabinoid CB1 receptor is a promising
therapeutic target for drug addiction, obesity,
and pain management. We study the role of the CB1
receptor in the reinforcing and rewarding
properties of cocaine, morphine, and palatable
foods using both behavioral pharmacology and
genetic knockout mouse technology.
Denise Dishongh, MA, LPCCSAT Travel
AwardProject Metamorphosis, Portland Oregon
  • Project Metamorphosis is a four agency
    collaborative effort designed to engage and
    encourage homeless youth to exit street life with
    innovative outreach, and customized
    youth-friendly services integrating alcohol and
    drug and mental health treatment within a
    comprehensive approach.

Joshua A. Lile, Ph.D.NIDA Women Gender Junior
Investigator Travel AwardMentor Thomas H.
Kelly, Ph.D.
  • My study has found that estradiol enhances the
    discriminative-stimulus and subject-rated effects
    of d-amphetamine in females. These data support
    the notion that estradiol increases the
    sensitivity to the effects of psychostimulant
    drugs such as d-amphetamine in females

Travel Award
  • I am the Clinical Director of the Wells Center, a
    not-for-profit substance abuse treatment center
    in West Central Illinois.  We provide
    detoxification, residential extended care,
    outpatient treatment and early intervention in
    the main facility in Jacksonville and in
    satellite offices and county probation offices in
    8 nearby rural counties.

Ginger L. Becker, B.A.Primm-Singleton Minority
Travel AwardMentor Charles P. France, Ph.D.
  • My research focuses on the use of drug
    discrimination and other behavioral and
    physiological indices to characterize conditioned
    withdrawal and the extent to which conditioned
    withdrawal increases self-administration of drugs
    in morphine-dependent non-human primates.


William Fantegrossi, Ph.D.CPDD Early Career
Investigator AwardMentors Anthony L. Riley,
Ph.D. John R. Glowa, Ph.D. James H. Woods,
Ph.D. Gail Winger, Ph.D. Leonard L. Howell,
My research examines drug effects in mice
behavioral paradigms such as drug discrimination
and food-maintained responding. In addition, I
work with rhesus monkeys trained to
self-administer hallucinogen-like drugs to gauge
the effects of drug history on neural and
behavioral endpoints, assessed via in vivo
microdialysis, PET neuroimaging, and operant
behavioral tasks.
Kathryn L. Hamilton, B.S.NIDA Director's Travel
AwardMentor Jonathan C. Gewirtz, Ph.D.
  • Opiate withdrawal produces affective and
    neuroendocrine changes, which negatively
    reinforce drug-taking behavior. My research is
    focused on characterizing the interaction between
    these two types of changes in a rodent model of
    methadone maintenance therapy.

Kate Vandegrift, MA, CAC, LPC CSAT Travel Award
Mentor Karol Kaltenbach, Ph.D.
  • I am the Program Director of MATER (Maternal
    Addiction Treatment Education and Research) at
    Jefferson Medical College, Philadelphia. We
    provide a continuum of care for drug dependent
    pregnant and parenting women and their children.
    I am a Member of the Philadelphia Domestic
    Violence Task Force and the Pennsylvania Womens
    Treatment Advocacy Consortium.

Ryan K. Lanier, Ph.D. NIDA Director's Travel
Award Mentors George E. Bigelow, Ph.D., Una D.
McCann, M.D., and Eric C. Strain, M.D.
  • I am conducting clinical pharmacology studies of
    addiction pharmacotherapies, especially tramadol
    and new formulations of buprenorphine, and
    evaluating the neuropsychological sequelae of
    drugs of abuse such as ecstasy at the Johns
    Hopkins Behavioral Pharmacology Research Unit.

Allison V. Schlosser, B.S.NIDA Women Gender
Junior Investigator Travel AwardMentor Catina
L. Callahan, M.S.W.
  • As a MSW student focusing on womens health, I am
    investigating the role that gender plays in the
    effectiveness of drug use prevention and
    treatment efforts, specifically focusing on
    highly vulnerable women. This knowledge will
    facilitate the tailoring of interventions to the
    specific needs of these women, ultimately making
    them more effective. 

Sara K. Chase. M.A. CPDD Early Career
Investigator Travel Award Mentor Steven J.
Ondersma, Ph.D.
  • Participant protection is vital in research
    involving stigmatized behaviors such as illicit
    drug use. My study compared disclosure of
    sensitive information under different consent
    conditions / levels of protection.

Christine M. Coyne, R.N., Ph.D.NIDA Women
Gender Junior Investigator Travel AwardMentor
Dennis M. Donovan, Ph.D.
  • During recovery, physical and psychological
    symptoms diminish health and the quality of life
    for women and may impact the well-being of their
    families. I studied the change in craving and
    symptom experience over the course of early
    recovery and examined the impact of craving and
    symptoms on recovery outcomes in women.

Robert Leeman, Ph.D. NIDA Director's Travel
AwardMentor Stephanie O'Malley, Ph.D.
  • I am a NIDA Postdoctoral Fellow in Psychiatry at
    Yale University School of Medicine. My research
    interests include issues of disinhibition/
    impulsivity and substance abuse, weight concerns
    and smoking and the synergy between alcohol use
    and smoking. I am about to begin a laboratory
    study to examine the effects of tobacco and food
    deprivation on smoking behavior.

Shanna Babalonis NIDA Women Gender Junior
Investigator Travel AwardMentor Thomas H.
Kelly, Ph.D.
  • I am currently exploring the manner in which
    hormones affect the behavioral and
    pharmacological mechanisms of drugs of abuse.
    Specifically, I am interested in hormonal
    modulation of the reinforcing and discriminative
    stimulus effects of certain drugs, with a focus
    on the modification of delay discounting

Rebekka S. Palmer, Ph.D. CPDD Early Career
Investigator Travel Award Mentor Samuel A.
Ball, Ph.D.
  • My research focuses on prevention and treatment
    of substance abuse and addictive behaviors among
    high risk populations. I have examined the
    prevalence of alcohol, drug (illicit and
    prescription), and tobacco use as well as
    gambling and sexual victimization.  I will
    evaluate the relationship between students drug
    use, number of negative consequences due to their
    use, and level of interest in an intervention and

Lynn M. Anderson, M.S. NIDA Women Gender
Junior Investigator Travel AwardMentor Dace S.
Svikis, Ph.D.
  • My research interests include tobacco use and
    dependence in special populations such as
    adolescents and pregnant women. My dissertation
    will focus on the validity of self-reported
    smoking behaviors in pregnant women.

Randall E. Rogers, Ph.D.NIDA Director's Travel
AwardMentor Stephen T. Higgins, Ph.D.
  • My training is in clinical health psychology and
    I am studying voucher-based reinforcement therapy
    with cocaine abusers. One of my research
    interests is the relationship between substance
    use and involvement in healthier, non-drug
    related activities in the natural environment. I
    am also interested in behavioral treatments for
    drug abuse.

Wendy Beth Bostwick, Ph.D., M.P.H.NIDA Women
Gender Junior Investigator Travel AwardMentor
Sean Esteban McCabe, Ph.D., M.S.W.
  • I am a recent graduate in Public Health and am
    interested in the epidemiology of substance use,
    particularly among sexual-minority women. In
    addition, my work explores the connection(s)
    between discrimination, stigma and substance use
    and mental health outcomes among lesbian, gay,
    bisexual and transgender populations.

Dede Howa, M.S.W. CSAT Travel Award
  • Through my experience in the substance abuse
    field, I have found that enhancing and
    implementing brief intervention services to
    college populations has been the most effective
    and rewarding work for me.  I believe that by
    providing brief intervention services to this
    population, we are possibly interrupting the path
    to addiction.

Vinita Batra NIDA Women Gender Junior
Investigator Travel AwardMentor Dr. Lisa
Schrott, Ph.D.
  • Oxycodone is an opioid analgesic used to
    alleviate mild to moderate pain. Being an opioid
    derivative in nature, its abuse potential has
    emerged significantly in U.S. My study focuses on
    the reproductive effects of chronic oxycodone
    treatment in female rats.

Kelly E. Dunn, Ph.D.NIDA Director's Travel
AwardMentor Stacey C. Sigmon, Ph.D.
I am currently using contingency management to
promote smoking cessation in methadone-maintained
patients. I am also working to develop and
evaluate the efficacy of a buprenorphine/
naltrexone therapy to treat prescription opioid
addiction. I am interested in learning how to
apply human behavioral pharmacological techniques
to facilitate drug abstinence.
Bethea A. Kleykamp, M.A.NIDA Women Gender
Junior Investigator Travel AwardMentor Thomas
E. Eissenberg, Ph.D.
Cognitive performance is impaired by tobacco
abstinence and reinstated by smoking or nicotine
replacement therapy (e.g., transdermal nicotine
TN). My study examined potential gender
differences in the cognitive effects of smoking
and TN in overnight-abstinent smokers.
Terry-Lee Howard, M.P.H.Primm-Singleton Minority
Travel AwardMentor Robert J. Jagers Ph.D.
  • Adolescent substance use is a pressing public
    health concern, especially for African American
    youth. My study will use baseline data from the
    Aban Aya Youth Project, to examine the
    co-occurrence of early substance use, violence
    and sexual behaviors among urban African-American
    fifth grade boys and girls.

Matt W. Feltenstein, Ph.D. NIDA Women Gender
Junior Investigator Travel AwardMentor Ronald
E. See, Ph.D.
Clinical research suggests that gender
differences exist in cocaine dependence. Using a
preclinical model, my research has focused on the
role of the estrous cycle and hormonal
influences on cocaine self-administration
and cocaine-primed reinstatement of drug seeking
Glenn R. Valdez, Ph.D. CPDD Early Career
Investigator Travel Award Mentor Roger D.
Spealman, Ph.D.
  • Stress appears to play a key factor in relapse to
    drug abuse.  The neurobiological mechanisms
    underlying regulation of stress-related relapse
    are still unclear. My research focuses on
    interactions between corticotrophin-releasing
    factor, kappa opioids, and norepinephrine in the
    reinstatement of cocaine-seeking behavior.

Amy A. Mericle, Ph.D. NIDA Director's Travel
AwardMentor Barbara E. Havassy, Ph.D.
I am a graduate of the University of Chicago and
currently am a post-doctoral fellow at the San
Francisco Treatment Research Center (TRC) at the
University of California. My research interests
include co-occurring substance use and mental
disorders, HIV/AIDS risk behaviors, and social
Liz Green, RN, BSN CSAT Travel Award
  • The House of Hope and Horizon House in Columbia,
    S.C., serve the homeless who suffer from mental
    illness and are dually diagnosed with a substance
    abuse disorder. The center provides services
    ranging from medical care to recreational
    therapy. I supervise and guide a
    multi-disciplinary staff assess needs
    coordinate staff and partner organization
    training and develop policies for program

Kathleen Ragsdale, Ph.D.NIDA Director's Travel
AwardMentors Bruce D. Johnson, Ph.D. and
Gregory Falkin, Ph.D.
Increases in more extreme forms of college
drinking (e.g., binging) are reported. We have
found that, while a random sample of college
students did not differ by gender according to
drinking, Greek-affiliated males were
significantly more likely to report engaging in
physical fights, while Greek-affiliated females
were significantly more likely to report being
taken advantage of sexually and engaging in
unwanted sex.
Chiquitia L. Welch, MSSA, MPA Primm-Singleton
Minority Travel AwardMentor Amelia Roberts,
  • The focus of my dissertation research is to
    develop research-based profiles of incarcerated
    adolescent females with substance use disorders.
    The aim is to inform targeted interventions and
    specific treatment approaches for incarcerated
    adolescent females with histories of substance
    misuse, substance use disorders, and serious

Carlos F. Rios-Bedoya, M.P.H., Sc.D. NIDA
Director's Travel AwardMentor James C. Anthony,
I am studying the transition from opportunity to
try to actual first use of drugs in adolescents
by assessing parental monitoring, deviant peer
affiliation, academic achievement,
neurodevelopmental and genetic factors with
special attention to ethnic differences. With
colleagues from Central, South America, and the
Caribbean we will further examine cultural and
regional differences.
Evan L. Riddle, Ph.D. CPDD Early Career
Investigator Travel Award Mentor Annette E.
Fleckenstein, Ph.D.
  • Psychostimulants potently alter dopamine
    signaling. My research centers on the effects
    that these agents exert on the activity and
    subcellular co-localization of neurotransmitter
    transporters and the association of these effects
    with the neurotoxic consequences of high-dose
    methamphetamine administration.

Kipling M. Bohnert NIDA Women Gender Junior
Investigator Travel AwardMentor James C.
Anthony, Ph.D.
I am a pre-doctoral fellow in Dr. Anthonys Drug
Dependence Epidemiology Training Program at
Michigan State University. My research focuses
on the epidemiology of cannabis and analgesic
Michael Levy, Ph.D. CSAT Travel Award
  • I am the Director of Clinical Treatment Services
    at CAB Health Recovery Services in MA. I
    oversee and improve the quality of treatment
    delivered across CABs continuum. I am a faculty
    member in Psychiatry at Harvard Medical School,
    have been PI of a number of CSAT and CDC grants
    and write a weekly newspaper column in which he
    responds to questions about addiction.

Brian S. Fulton Ph.D. NIDA Director's Travel
AwardMentor John L. Neumeyer Ph.D.
I am currently focused on the synthesis and study
of new ligands that bind selectively to opioid
receptors for the treatment of cocaine abuse and
dependence. We are interested in the synthesis
and pharmacology of morphinan based bivalent
ligands that are selective agonists at mu/kappa
receptors and their use to explore receptor
dimerization in addiction processes.
Emma Childs, Ph.D.NIDA Women Gender Junior
Investigator Travel AwardMentor Harriet de
Wit, Ph.D.
One way in which acute stress may affect
drug-taking behavior is by directly altering the
physiological and/or subjective effects of drugs.
Our study was designed to characterize the
time-course of physiological, psychological and
hormonal responses to acute stress in men and
women and in smokers and nonsmokers.
Venusha Moodley, M.P.H.NIDA Director's Travel
AwardMentor Emmalee S. Bandstra, M.D.
My research career has enabled me to work with
adolescents who may have been prenatally exposed
to cocaine. Substance abuse continues to
negatively impact the growth and development of
children. I hope to expand the scope of my
research to include interventions geared toward
the prevention of problems that arise from the
cyclical nature of drug abuse.
Jennifer L. Newman, Ph.D.NIDA Women Gender
Junior Investigator Travel AwardMentor Marilyn
E. Carroll, Ph.D.
Examining factors that mediate the reinforcing
effects of drugs is critical for developing
effective treatment approaches. My research
focuses on the role of ovarian steroid hormones
and other pharmacological mechanisms influencing
drug self-administration.
David E. Moorman, Ph.D.NIDA Director's Travel
AwardMentor Laura L. Peoples, Ph.D.
I am interested in understanding the cellular
basis of the plasticity underlying cocaine
addiction. I am recording from single neurons in
the rat orbitofrontal cortex during cocaine and
sucrose self-administration to investigate how
such neural activity contributes to drug seeking
and taking behaviors and to understand how
dysfunction of the area may be involved in drug
Teresa J. Linares Scott, M.A.Primm-Singleton
Minority Travel AwardMentor Lynn T. Singer,
  • Prenatal substance exposure can have a lasting
    impact on children's development. I evaluated
    aggressive behaviors in a large sample of
    cocaine-exposed children who were 9 years of age
    at assessment. I continue working with children
    and mothers impacted by maternal substance use
    during pregnancy, focusing specifically on mental
    health outcomes.

Jennifer R. Havens, Ph.D., M.P.H. NIDA Women
Gender Junior Investigator Travel AwardMentor
Carl G. Leukefeld, D.S.W.
My research interests include the epidemiology of
prescription opioid misuse, drug use among
pregnant women, and comorbid psychopathology
among drug users
Noosha Niv, Ph.D. NIDA Director's Travel
AwardMentors Yih-Ing Hser, Ph.D. and Rick
Rawson, Ph.D.
Current projects include the development of a
cognitive-behavioral intervention for comorbid
substance abuse and psychotic disorders and an
analysis of ethnic differences in utilization of
mental health services and outcomes among
drug-abusing patients with mental health problems.
Sarah Church, Ph.D. CSAT Travel Award Mentor
Ira J. Marion, MA.
  • I am the Associate Executive Director of the
    Division of Substance Abuse at the Albert
    Einstein College of Medicine. I am currently in
    an administrative role, but in previous positions
    I conducted research to develop novel
    psychosocial and psychopharmacological
    interventions for opioid and cocaine dependence.

Samuel A. Roiko, B.S.NIDA Director's Travel
AwardMentor Paul Pentel, M.D.
Immunotherapy provides a new strategy to treat
addiction by targeting the drug rather than the
brain. My thesis project is focused on the
effects of passive immunization (using
nicotine-specific monoclonal antibodies) on
nicotine pharmacokinetics and behaviors relevant
to nicotine addiction in rats.
Elizabeth K. ReynoldsNIDA Women Gender Junior
Investigator Travel AwardMentor Carl Lejuez,
I am currently studying the role of theoretically
relevant personality (i.e., negative
emotionality, and impulsivity) and environmental
(history of sexual abuse) variables as potential
underlying mechanisms (i.e., mediators) of the
relationship between gender and drug choice among
patients in an inner-city residential substance
abuse treatment program.
Laura L. Chivers, B.A. NIDA Director's Travel
AwardMentor Stephen T. Higgins, Ph.D.
My current research focus is early abstinence and
the influence of non-pharmacological factors on
drug self-administration. My project examines the
influence of duration of abstinence and of
programmed smoking lapses on withdrawal and
related participant ratings and on the relative
reinforcing effects of smoking.
Ted Millard, M.S.W. CSAT Travel Award
  • I am the Executive Director of a residential
    treatment program for adult males. I have worked
    in the addiction field for twenty-six consecutive
    years. In my spare time I am active as a trainer
    and wish-granter for the Make-A-Wish Foundation
    of New Jersey.

Laurence L. Miller, M.A.NIDA Director's Travel
AwardMentor Linda A. Dykstra, Ph.D.
The glutamate system has been shown to play a
role in the behavioral effects of opioids. I am
studying mice with a partial deletion of the NR1
subunit of the NMDA receptor as a way to examine
the involvement of the glutamate system in
several effects of morphine, in particular its
rewarding effects as displayed in the conditioned
place preference procedure.
Trudy A. Smith Primm-Singleton Minority Travel
AwardMentor Andrew Coop, Ph.D.
  • Prescription opioid analgesics suffer from the
    side effects of tolerance and dependence. My
    research is focused on the design and synthesis
    of analogs that reduce/eliminate these side

Ty S. Schepis, B.S. NIDA Director's Travel
AwardMentor Uma Rao, M.D.
My current research is focused on smoking
cessation for adolescents, particularly in
subgroups of adolescents, such as those with a
history of depression. In addition, I am
interested in prescription stimulant abuse and
diversion, and I am currently examining the
availability of stimulants without a prescription
via the internet.
Justin J. Anker NIDA Women Gender Junior
Investigator Travel AwardMentor Marilyn E.
Carroll, Ph.D
I am interested in endogenous factors that
influence various phases of the drug addiction
process. My studies examine the effects of
progesterone and estrogen on the reinstatement of
cocaine seeking, and the interaction between sex,
saccharin preference, and impulsivity on the
self-administration of cocaine in female rats.
Sel J. Wahng, Ph.D.NIDA Director's Travel
AwardMentor Larry Nuttbrock, Ph.D.
Focusing on male-to-female transgendered persons
in New York City, I am conducting a quantitative
epidemiological longitudinal initiative measuring
gender identity, identity development, substance
use, depression, and HIV/STD risk factors. I am
also performing a self-initiated qualitative
investigation examining African Americans,
Latina/os, and Asians in relation to HIV/STD risk
Kevin P. Hill, M.D. CPDD Early Career
Investigator Travel Award Mentor Mehmet
Sofuoglu, M.D. Ph.D.
  • As a Robert Wood Johnson Clinical Scholar at
    Yale, I study the effects of atomoxetine on
    stress response in healthy subjects. The
    attenuation of responses to physiological,
    psychological, and pharmacological stressors may
    provide a rationale for further study of
    noradrenergic medications as treatments for
    stimulant addiction.

Jeffery C. BatisNIDA Women Gender Junior
Investigator Travel AwardMentor Scott Bowen,
My studies examine the biobehavioral sequelae
associated with inhalant abuse as a function of
age at time of exposure. My research has
revealed that earlier exposure, particularly
during the prenatal or adolescent stages, leads
to a variety of adverse outcomes not seen in
adult animals given equivalent exposures.
Amy Bloch, LISW, CADCCSAT Travel Award
  • I am the Program Director of Outpatient Services
    at Jackson Recovery Centers in Sioux City, Iowa.
    I am responsible for clinical programs that
    service over 2000 patients per year. My
    responsibilities include marketing, developing
    and managing budgets for 8 clinical programs,
    staff supervision, and program development and

Andrea H. Weinberger, Ph.D.NIDA Women Gender
Junior Investigator Travel AwardMentor Tony
P. George, M.D.
My research focuses on combining pharmacological
and behavior treatments for nicotine dependence
to improve cessation outcomes and prevent or
delay relapse to smoking. My study investigates
gender differences in smoking expectancies for
smokers in a pharmacological trial of Selegiline
(an MAO-B inhibitor) for smoking cessation.
Raquel Fosados, M.P.H. Primm-Singleton Minority
Travel Award Mentor Yih-Ing Hser, Ph.D.
  • My current research centers on the cultural and
    ethnic factors associated with adolescent
    substance use. My most recent work focuses on
    ethnic disparities in the utilization of
    substance abuse treatment services among
    Californias Proposition 36 clients.

Stacey B. Daughters, Ph.D. CPDD Early Career
Investigator Travel Award Mentor C.W. Lejuez,
  • My research focuses on distress tolerance as a
    predictor of early treatment dropout and relapse
    across addictive disorders as well as the
    development and persistence of substance use
    among adolescents. I also use behavioral
    activation strategies in the context of standard
    substance abuse treatment for patients with
    elevated depressive symptoms.

Susie Ruiz, J.D., L.M.S.W., M.A.C.,
C.C.J.A.P.CSAT Travel Award Mentor Emmitt
Hayes, Jr.
  • As the Clinical Case Work Manager for the
    Juvenile Justice Integrated Network, I supervise
    a day treatment program and the respective
    counselors/staff. I have been instrumental in the
    development of the Department multidisciplinary
    staffing process which allows for identification
    of client strengths and needs.

Marc L. Copersino, Ph.D.NIDA Women Gender
Junior Investigator Travel AwardMentors Roger
D. Weiss, M.D. David A. Gorelick, M.D., Ph.D.
There are few data on the experience of
spontaneous cessation of cannabis use in adults,
especially with regard to the effects of gender.
I examined gender differences in retrospectively
self-reported characteristics of spontaneous
cannabis quitting among non-treatment-seeking,
adult cannabis smokers.
Brian O. Butler, M.S., L.P.C.CSAT Travel Award
Mentor Sonia Jackson
  • I am currently expanding substance abuse
    programming to better serve co-occurring-
    disordered populations, gender-specific substance
    abuse treatment for women with dependent
    children, and substance abusing, pregnant women.
    I research and develop innovative,
    evidenced-based treatments for returning
    combat-zone veterans in acute treatment settings.

Deborah John Rinehart, M.A.NIDA Women Gender
Junior Investigator Travel AwardMentor Karen
Fortuin Corsi, Sc.D., M.P.H.
HIV among women is an increasing public health
concern.  My study investigated gender
differences in a group of injection drug users
and found that more women are engaging in risky
injection and sex behaviors when compared to
men.  In addition, regression analyses identified
variables related to HIV risk behaviors for
Joanne Kurt-Hilditch, BSCJ, CSAC IICSAT Travel
  • I am the Quality Assurance Director for the
    Kansas City Community Center, a non-profit
    organization that provides substance abuse
    treatment services in prisons and the community
    throughout Missouri. I devise and implement
    curriculum and update resources, ensuring
    compliance with mandated State standards and
    ensuring appropriate care for our clientele.

Matthew J. Carpenter, Ph.D. CPDD Early Career
Investigator Travel Award Mentor Himanshu
Upadhyaya, M.B.B.S., M.S.
  • In laboratory-based investigations of cue
    reactivity, nicotine-dependent individuals report
    high levels of craving in response to
    tobacco-related cues. It is unclear whether
    individuals' responses to cues extinguish over
    repeated laboratory sessions. Our study examines
    the persistence of cue
  • reactivity across multiple experimental sessions.

Kevin T. Ball, B.A.NIDA Director's Travel
AwardMentor George V. Rebec, Ph.D.
My research focuses on the neural mechanisms
underlying changes in behavior following exposure
to drugs of abuse. I have focused on the effects
of the popular club drug MDMA (ecstasy) on brain
and behavior. Results from these investigations
have revealed that MDMA exposure is associated
with enduring behavioral and neuronal plasticity
in striatum.
Qi Wan, M.D. CPDD Early Career Investigator
Travel Award Mentor Wen-Zhe Ho, M.D.
  • Opioids and Substance P are potent modulators of
    neuro-immunoregulation. The biological
    interaction of opioids, Substance P and the
    neurokinin-1 Receptor (NK-1R) pathway is of
    particular interest. Our research is focused on
    the effects of morphine on expression and
    function of NK-1R in the central nervous system.

Konstantin Dumchev, M.D., M.P.H. WHO/NIDA/CPDD
International Travel Award Mentor Joseph E.
Schumacher, Ph.D.
I am currently a physician at Methodology
Statistics Core, Vinnitsya Regional Narcological
Dispensary, Vinnitsya, Ukraine. My research
interests include opiate dependence, treatment,
blood-borne infections. Recently I have studied
predictors of HIV and HCV status in IDUs in
Vinnitsya, Ukraine, and transporting behavioral
treatment for opiate IDUs in Ukraine.
Katherine Keyes, B.A. NIDA Women Gender Junior
Investigator Travel Award Mentor Deborah
Hasin, Ph.D.
I am an Assistant Research Scientist working on
projects involving the National Epidemiologic
Survey on Alcohol and Related Conditions and
other large-scale datasets. Concurrently, I am
pursuing an MPH in epidemiology from Columbia
University, and was recently awarded a
pre-doctoral fellowship in psychiatric
epidemiology to continue my studies at the
doctoral level.
Richard R. Swanson CSAT Travel Award
  • Brings 35 years of experience providing substance
    abuse treatment and prevention services to a four
    county, rural area of Southeast Iowa.  Services
    include ASAM Levels I through III.7 in the
    context of a modified therapeutic community.

Jin H. Yoon, Ph.D.NIDA Director's Travel
AwardMentor Stephen T. Higgins, Ph.D.
I am currently working with pregnant women in a
clinical-outcomes based research center. One
general area of research interest is the
relationship between delay discounting and drug
abuse. Additionally, I am also interested in
contingency management and it's role in
facilitating drug treatment.
Nehal P. Vadhan, Ph.D. CPDD Early Career
Investigator Travel Award Mentor Richard W.
Foltin, Ph.D.
  • I employ neuropsychological and behavior
    pharmacological methods to study learning ability
    and executive function of cocaine and marijuana
    abusers under conditions of abstinence and
    intoxication Knowledge of the long-term cognitive
    effects of these drugs will assist in the
    development of more effective cognitive-behavioral

Glenda Springsted-Spencer, M.A.CSAT Travel Award
  • I am the Director of Addiction Services at a
    residential treatment program in Cando, ND.  My
    project was to develop the Center for Solutions
    Alumni Association and a website that provides
    the Alumni with the means of maintaining ongoing
    relationships. I love to learn, and am excited to
    explore the latest information in blending
    research and addiction treatment.  

Erica Peters, B.A.NIDA Director's Travel
AwardMentor John Hughes, M.D.
I am a predoctoral student investigating the
natural history of reduction and cessation
attempts by tobacco smokers.  I am investigating
the efficacy of gradual vs. abrupt smoking
cessation, the rate of relapse to smoking after
one year of abstinence, and the natural history
of attempts by marijuana users to quit.  I plan
to study the effect of marijuana abstinence on
the use of other drugs.
Shane A. Perrine, Ph.D. CPDD Early Career
Investigator Travel Award Mentor Ellen M.
Unterwald, Ph.D.
  • I study the neuropharmacological and behavioral
    effects of cocaine focusing on dopamine and
    opioid signaling and interactions. I have found
    that 1-day withdrawal from chronic binge-pattern
    cocaine desensitized delta-opioid receptors in
    rat striatum and increased anxiety- and
    depression-like measures, behaviors that are
    blocked by pretreatment with the delta-opioid
    agonist SNC-80.

Min Zhao, M.D., Ph.D. WHO/NIDA/CPDD
International Travel Award Mentor Walter
Ling, M.D.
My research interests include genetic, clinical
and intervention influences on craving and drug
dependence and HIV, HCV and other infectious
diseases among IDUs. I am actively involved in an
international collaboration between China and
other countries.
Marlena Clemons, L.C.D.C.CSAT Travel Award
  • I provide both residential and outpatient
    treatment services to adolescents and adults. 
    Currently, my focus is on providing services to
    residents in a rural area of South Texas where
    minimal resources are available. I am the Program
    Director of an Outpatient Treatment program for
    the Brush Country Council on Alcohol Drug Abuse
    in Floresville, Texas.

Karen F. Corsi, Sc.D., M.P.H. CPDD Early Career
Investigator Travel Award Mentor Robert E.
Booth, Ph.D.
  • Methamphetamine is a serious and growing problem
    in the U.S. People who use methamphetamine are at
    risk for a host of health problems and diseases,
    including HIV and Hepatitis C. My study
    investigated injection drug users who use meth
    and found that they are at high risk for HIV due
    to their risky injection practices.

Penny Henderson, LAC, CCS, CCGC, SAP, ICADC
CSAT Travel Award
  • I am a Masters Level Licensed Addictions
    Counselor, Administrator of Acadiana Recovery
    Center and owner of HERS L.L.C.  I am a certified
    Clinical Supervisor and Crisis Prevention
    Supportive Intervention Instructor,  President
    Elect of the Louisiana Association of Substance
    Abuse Counselors and Trainers and the recipient
    of the 2005 Louisiana Counselor of the Year Award.

Jay Elliott, Ph.D. CPDD Early Career
Investigator Travel Award Mentor Ronald E. See,
  • My project sought to explore potential mechanisms
    through which the dorsal striatum structure
    influences the expression of cocaine-seeking
    behavior. I evaluated the role of dopamine D1 and
    ionotropic glutamate receptors in the
    dorsolateral caudate/putamen as mediators of
    relapse in a rat model of reinstatement.

Patricia. A. Woicik, Ph.D. NIDA Director's
Travel AwardMentor Rita Z. Goldstein, Ph.D.
My study examined relationships between
personality and performance based measures of
inhibitory control in cocaine abusers. Results fro
m this research suggest that drug-addicted
individuals who report greater positive
emotionality and self control may in fact have
impaired insight to their deficits.
Betty Streett, MSSW, LCSW CSAT Travel Award
  • I direct chemical dependency programs for a
    regional mental health center, including a 54 bed
    residential unit for adults (including pregnant
    and parenting women), and a 24 bed adolescent
    residential center.  I wrote the initial grants
    for these programs.  I write articles and books
    on chemical dependency and spirituality.

Sabrina Ford, Ph.D.NIDA Director's Travel
AwardMentor Hallam Hurt, M.D.
Risk behaviors in adolescents, such as drug use,
conduct problems, and high-risk sex are serious
and may lead to adverse health outcomes later in
life. My research involves the exploration of
neurocognitive correlates of such risk behaviors
in an effort to inform regarding prevention and
treatment measures.
Rinah T. Yamamoto, Ph.D. NIDA Women Gender
Junior Investigator Travel Award Mentor Marc
J. Kaufman, Ph.D.
Among chronic cocaine abusers, males are more
vulnerable than females to cocaines adverse
brain and vascular effects. My study
investigated physiological, pharmacokinetic, and
behavioral responses to the combined effects of
IV cocaine and altered gonadal hormone status in
cocaine using men.
James Willis, Sr, MS, LPC, LSATP CSAT Travel
  • I am the Program Director for the Substance Abuse
    Therapeutic Community Program for incarcerated
    males (Chesapeake, VA). By utilizing client
    evaluations in the clinical assessment, we are
    capturing data to enhance program efficiency. Our
    research provides the opportunity to clearly
    measure treatment necessities, clarify remaining
    treatment needs and target areas of focus in the
    last phase of treatment.

Gregory Breeden, Ph.D., M.P.H.NIDA Women
Gender Junior Investigator Travel Award Mentor
Margaret Ensminger, Ph.D.
My dissertation research investigated factors
that determined perceptions of racial
discrimination, their impact on frequency of
cocaine and marijuana drug use, and gender
differences in these factors. I am currently
continuing my research as the Paul B. Cornely
Postdoctoral Scholar at the Center for Research
on Ethnicity, Culture and Health (CRECH) at the
University of Michigan.
Arpana Agrawal, Ph.D. CPDD Early Career
Investigator Travel Award Mentors Pamela A.F.
Madden, Ph.D. Andrew C. Heath, D.Phil.
  • My research focuses on the genetic epidemiology
    of cannabis use, abuse and dependence. This year,
    I present findings from a study of 13 genetic
    models of comorbid cannabis and other illicit
    drug use and problems. I also study the role of
    genomic regions and candidate genes for cannabis
    and other illicit drug use disorders.

Wendy Donlin, Ph.D.NIDA Director's Travel
AwardMentor Kenneth Silverman, Ph.D.
As a post-doctoral fellow in the Behavioral
Pharmacology Research Unit at the Johns Hopkins
School of Medicine, I am examining the efficacy
of employment-based reinforcement interventions
on drug abstinence and ingestion of naltrexone.
I am interested in conducting research on the use
of contingency management interventions for
treating drug abuse.
Sylvia Fitting, M.A. CPDD Early Career
Investigator Travel Award Mentors Charles F
Mactutus, Ph.D. Rosemarie M Booze, Ph.D.
  • Neurological complications continue to be
    manifest in the HIV-1 type 1 infected population.
    Focusing on NeuroAIDS, my research examines
    developmental neurotoxic effects of the HIV-1
    proteins, Tat and gp120, on neurobehavioral and
    anatomical measures in an animal model.

Jermaine Jones, M.S. Primm-Singleton Minority
Travel AwardMentor Anthony L. Riley, Ph.D.
  • Most commonly abused drugs have rewarding and
    aversive properties which both contribute to
    their abuse liability. My research focuses on the
    pharmacological basis of the aversive affective
    properties of cocaine, with specific
    concentration on the role of dopamine,
    norepinephrine and serotonin transporter

Thomas Moore, M.S., M.A.CSAT Travel Award
  • I am the Clinical Director of Life Guidance
    Services, a division of Proaction Behavioral
    Health Alliance of Grand Rapids, Michigan.
    Current duties include professional development
    of clinical staff through training and
    supervision, especially in co-occurring
    Disorders, Motivational Interviewing and
    Evidence-based Practice, as well as program
    design and implementation.


Lawrence P. Carter, Ph.D.CPDD Early Career
Investigator AwardMentor Roland R. Griffiths,
Gamma-hydroxybutyrate (GHB) is a putative
neurotransmitter, a drug of abuse, and a novel
therapeutic for narcolepsy. My previous research
helped identify and characterize pharmacological
mechanisms of action of GHB using behavioral
procedures in rodents. My current research
examines the abuse liability and cognitive
effects of GHB in human volunteers.
Shari Spies, Psy.D.CSAT Travel Award
  • I am the Clinical Director for a Behavioral
    Health Network in New Mexico which serves the
    Native American communities.  I received my
    doctorate degree in Clinical Psychology in 1999,
    but have worked in the addictions and mental
    health fields for 20 years.  My areas of
    expertise are the treatment of adults with
    co-occurring disorders, esp. mental health and

Jeffrey S. Gonzalez, Ph.D. NIDA Director's
Travel AwardMentor Steven A. Safren, Ph.D.
I study psychosocial approaches to treatment
adherence issues in chronic illness, especially
HIV.  I am currently conducting a randomized
clinical trial to examine the efficacy of a
cognitive behavioral therapy intervention to
improve medication adherence and decrease
depression in HIV patients on methadone
maintenance.  The data will inform the adaptation
of this intervention for use with HIV
monolingual Latinos. 
Brian C Kelly, Ph.D.NIDA Women Gender Junior
Investigator Travel Award Mentor Jeffrey T
Parsons, Ph.D.
I am a medical anthropologist studying drug use,
sexual health, and youth cultures. I conduct
research in the New York City metropolitan area
and the foci of my current projects include club
drug use among NYC metropolitan area young
adults, drug dealing among suburban youth, and
the emerging trend of tryptamine use.
Jesse Jong-Shik Suh, Psy.D. NIDA Director's
Travel AwardMentor Anna Rose Childress, Ph.D.
My research has demonstrated that lower resting
perfusion in the anterior cingulate cortex
predicts increased depressive symptoms in
treatment-seeking cocaine patients, pointing to a
potential source of relapse vulnerability. My
ongoing work is focused on novel brain-behavioral
probes of affect dysregulation in adult substance
abusers and in adolescents at-risk for addiction.
Benjamin P. Kowal, Ph.D. NIDA Women Gender
Junior Investigator Travel Award Mentor Warren
K. Bickel, Ph.D.
My studies demonstrated that females tend to
discount temporally distant rewards less than
males across reward classes (i.e., money and
cigarettes) and direction in time (i.e., past
gains or future gains). Different survival goals
may influence differences in temporal discounting
among males and females.
Wei Hua, M.D., M.S., M.H.S. NIDA Director's
Travel AwardMentor Carl Latkin, Ph.D.
My research focuses on HCV mono-infection and its
co-infection with HIV, as well as specific risk
behavior patterns, among injection drug users in
a social network context. Such knowledge may
provide insight into HCV transmission dynamics in
the era of HIV and may direct appropriate HIV/HCV
combined prevention intervention efforts.

Mary A. Hatch-Maillette, Ph.D. CPDD Early Career
Investigator AwardMentors Donald A. Calsyn,
I am a Research Scientist at the University of
Washington Alcohol and Drug Abuse Institute.  My
research and clinical interests include substance
abuse, HIV/AIDS, gender specific addiction
treatment, and PTSD.  Since 2003, I have overseen
NIDA-funded clinical trials at treatment programs
in Washington state and nationally.
David Hamolsky, Psy.D. CSAT Travel Award
  • I am the Project Director for the Moving On
    Program at LUK, Inc, and Director of LUK's
    Behavioral Health Clinic. I work with our local
    child welfare agency to implement an extension of
    MET/CBT5 utilizing another evidenced-based model
    Assertice Continuing Care (ACC), an outreach case
    management model intended to sustain and
    supplement gains made in substance abuse

Danielle E. Ramo, M.S.CPDD Early Career
Investigator AwardMentor Sandra A. Brown, Ph.D.
  • I am currently studying whether a diagnosis of
    depression while in inpatient substance abuse
    treatment or more proximal depression symptoms
    are associated with relapse. Results reveal that
    proximal symptoms, rather than a diagnosis of
    depression, put youth at risk for relapse after

Matt Stricherz CSAT Travel Award
  • Direct an on-campus State Accredited alcohol and
    drug treatment program. Since 1998 we have
    trained about 6600 students in the identification
    and management of Alcohol Poisoning and we have
    initiated Drunk Drugged Driving programs and
    have reduced DWIs in our target population of
    USD students by over 35 in 3 years

  • Marcy J. Bubar, Ph.D.
  • Center for Addiction Research
  • University of Texas Medical Branch
  • Galveston, Texas
Write a Comment
User Comments (0)
About PowerShow.com